Fuan Pharmaceutical Group Co Ltd
SZSE:300194
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Fuan Pharmaceutical Group Co Ltd
Net Income (Common)
Fuan Pharmaceutical Group Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fuan Pharmaceutical Group Co Ltd
SZSE:300194
|
Net Income (Common)
¥144.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
10%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥5.6B
|
CAGR 3-Years
29%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥8.1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥5.2B
|
CAGR 3-Years
20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Net Income (Common)
¥6.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
14%
|
CAGR 10-Years
33%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Net Income (Common)
-¥1.1B
|
CAGR 3-Years
-55%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fuan Pharmaceutical Group Co Ltd
Glance View
Fuan Pharmaceutical (Group) Co., Ltd. is engaged in the research and development, manufacture, and sale of active pharmaceuticals and formulation. The company is headquartered in Chongqing, Chongqing and currently employs 3,004 full-time employees. The company went IPO on 2011-03-22. is a China-based company principally engaged in the sales of Active Pharmaceutical Ingredients (APIs) and intermediates, preparations and pharmaceuticals. The firm's pharmaceutical products mainly include antibiotics, anti-tumor medicines, respiratory system medicines and specialty medicines. The firm distributes its products in domestic market and to overseas markets.
See Also
What is Fuan Pharmaceutical Group Co Ltd's Net Income (Common)?
Net Income (Common)
144.5m
CNY
Based on the financial report for Sep 30, 2025, Fuan Pharmaceutical Group Co Ltd's Net Income (Common) amounts to 144.5m CNY.
What is Fuan Pharmaceutical Group Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
10%
Over the last year, the Net Income (Common) growth was -49%.
